Home › Funds › Lazard Asset Management › AZN

Lazard Asset Management position in AZN

ASTRAZENECA PLC · Health Care

Lazard Asset Management reported holding 2,332,566 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$438.1M, representing 0.68% of its reported portfolio and ranking #27 among its reported holdings. Lazard Asset Management has disclosed AZN holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

Latest position (Q2 2026)2.33M sh
Reported value held$438.11M
Portfolio Weight0.68%
First reportedQ3 2021
Last changeAdd
Updated2026-10-05

Last updated: 2026-10-05 · Source: SEC EDGAR Form 13F-HR

How Lazard Asset Management's AZN position evolved

Lazard Asset Management first disclosed a stake in AZN in Q3 2021 at 812,783 shares (US$48.8M). The position peaked in Q2 2026 at 2,332,566 shares, worth US$438.1M. Across 20 filings, Lazard Asset Management increased the stake 11 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 2,332,566 shares valued at US$438.1M — an increase of 115,679 shares quarter over quarter.. Notable position changes include a 94% trim in Q1 2022 (shares were roughly flat over the following quarter), a 2726% increase in Q1 2023 (shares rose 3% over the following quarter), a 298% increase in Q2 2024 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 812.78K $48.81M New
Q4 2021 57.66K $3.36M Reduce
Q1 2022 3.73K $246.00K Reduce
Q2 2022 3.37K $221.00K Reduce
Q3 2022 3.37K $183.00K Hold
Q4 2022 3.86K $260 Add
Q1 2023 109.14K $7.57K Add
Q2 2023 159.05K $11.38K Add
Q3 2023 283.56K $19.20K Add
Q4 2023 354.12K $23.85K Add
Q1 2024 482.73K $32.70K Add
Q2 2024 1.92M $149.79K Add
Q3 2024 1.16M $90.44K Reduce
Q4 2024 918.67K $60.19K Reduce
Q1 2025 1.13M $82.96K Add
Q2 2025 1.13M $78.75K Hold
Q3 2025 1.33M $102.39M Add
Q4 2025 1.34M $122.93M Hold
Q1 2026 2.22M $432.81M Add
Q2 2026 2.33M $438.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 70 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has Lazard Asset Management held AZN?

Lazard Asset Management has disclosed AZN holdings in 20 of the last 20 reported quarters, going back to Q3 2021.

What is Lazard Asset Management's current position in AZN?

As of Q2 2026, Lazard Asset Management holds 2.33M shares of AZN (ASTRAZENECA PLC), valued at $438.11M, representing 0.68% of its reported portfolio and ranking #27.

Has Lazard Asset Management been buying or selling AZN?

In the latest 13F filing (Q2 2026), Lazard Asset Management increased its position in AZN. The position peaked in Q2 2026 at 2.33M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.